Tutrone W D, Kagen M H, Barbagallo J, Weinberg J M
Department of Dermatology, St. Luke's-Roosevelt and Beth Israel Medical Centers, New York, New York 10025, USA.
Cutis. 2001 Dec;68(6):367-72.
This article, the second in a 2-part series, will review interleukin 10 (IL-10) administration, the T-cell receptor mimic peptide, and CTLA4Ig. We also will review 4 of the most promising therapies currently being investigated for the treatment of psoriasis: infliximab, etanercept, efalizumab, and alefacept.
本文是系列文章的第二篇，将对白细胞介素10（IL-10）给药、T细胞受体模拟肽以及CTLA4Ig进行综述。我们还将综述目前正在研究的用于治疗银屑病的4种最具前景的疗法：英夫利昔单抗、依那西普、依法利珠单抗和阿法赛特。
